Literature DB >> 10746355

Brain function in the elderly: role of vitamin B12 and folate.

D G Weir1, J M Scott.   

Abstract

Vitamin B12 (cobalamin) deficiency associated neuropathy, originally called subacute combined degeneration, is particularly common in the elderly. The potential danger today is that with supplementation with folic acid of dietary staples such as flour, that the incidence of this disease could rise as folic acid, as opposed to natural folate (N5CH3HFGlu1), enters the cell and the metabolic cycle by a cobalamin independent pathway. This chapter briefly describes the clinical presentation of the disease, which unless treated will induce permanent CNS damage. The biochemical basis of the interrelationship between folate and cobalamin is the maintenance of two functions, nucleic acid synthesis and the methylation reactions. The latter is particularly important in the brain and relies especially on maintaining the concentration of S-adenosylmethionine (SAM) which, in turn, maintains the methylation reactions whose inhibition is considered to cause cobalamin deficiency associated neuropathy. SAM mediated methylation reactions are inhibited by its product S-adenosylhomocysteine (SAH). This occurs when cobalamin is deficient and, as a result, methionine synthase is inhibited causing a rise of both homocysteine and SAH. Other potential pathogenic processes related to the toxic effects of homocysteine are direct damage to the vascular endothelium and inhibition of N-methyl-D-aspartate receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10746355     DOI: 10.1258/0007142991902547

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  22 in total

1.  Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification.

Authors:  Martha Savaria Morris; Paul F Jacques; Irwin H Rosenberg; Jacob Selhub
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

2.  Diffusion tensor tractography and neuropsychological assessment in patients with vitamin B12 deficiency.

Authors:  Pradeep Kumar Gupta; Ravindra Kumar Garg; Rakesh Kumar Gupta; Hardeep Singh Malhotra; Vimal Kumar Paliwal; Ram Kishore Singh Rathore; Rajesh Verma; Maneesh Kumar Singh; Yogita Rai; Chandra Mani Pandey
Journal:  Neuroradiology       Date:  2013-12-10       Impact factor: 2.804

3.  A quantitative proteomic approach for unveiling novel mechanisms associated with MeHg-induced toxicity: effects on the methylation cycle.

Authors:  Pablo Cabezas-Sanchez; Estefania Garcia-Calvo; Carmen Camara; Jose L Luque-Garcia
Journal:  Toxicol Res (Camb)       Date:  2015-11-13       Impact factor: 3.524

4.  Vitamin B12 and Homocysteine Associations with Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging.

Authors:  M L Vidoni; K Pettee Gabriel; S T Luo; E M Simonsick; R S Day
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs.

Authors:  Kira Leishear; Luigi Ferrucci; Fulvio Lauretani; Robert M Boudreau; Stephanie A Studenski; Caterina Rosano; Rosanna Abbate; Anna M Gori; Anna M Corsi; Angelo Di Iorio; Jack M Guralnik; Stefania Bandinelli; Anne B Newman; Elsa S Strotmeyer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-12       Impact factor: 6.053

6.  Short-term influence of elevation of plasma homocysteine levels on cognitive function in young healthy adults.

Authors:  P Alexopoulos; S Lehrl; T Richter-Schmidinger; A Kreusslein; T Hauenstein; F Bayerl; P Jung; T Kneib; A Kurz; J Kornhuber; S Bleich
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

7.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

8.  Conversion from mild cognitive impairment to dementia: influence of folic acid and vitamin B12 use in the VITA cohort.

Authors:  I Blasko; M Hinterberger; G Kemmler; S Jungwirth; W Krampla; T Leitha; K Heinz Tragl; P Fischer
Journal:  J Nutr Health Aging       Date:  2012-08       Impact factor: 4.075

9.  Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Authors:  Gwenaëlle Douaud; Helga Refsum; Celeste A de Jager; Robin Jacoby; Thomas E Nichols; Stephen M Smith; A David Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

10.  Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer's Disease.

Authors:  Sung Rae Kim; Seong Hye Choi; Choong Kun Ha; Shin Goo Park; Hae Wook Pyun; Dae Hyun Yoon
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.